Compagnie Lombard Odier S Cm A Repare Therapeutics Inc. Transaction History
Compagnie Lombard Odier S Cm A
- $6.12 Billion
- Q3 2024
A detailed history of Compagnie Lombard Odier S Cm A transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 14,000 shares of RPTX stock, worth $17,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,000
Previous 14,000
-0.0%
Holding current value
$17,080
Previous $46,000
4.35%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RPTX
# of Institutions
64Shares Held
35.4MCall Options Held
51KPut Options Held
300-
Bvf Inc San Francisco, CA10.3MShares$12.6 Million1.13% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$4.11 Million3.82% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.05 Million0.27% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$3.62 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.23 Million23.86% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $51.2M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...